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Huntingtin (HTT) fragments with extended polyglutamine tracts self-assemble into amyloid-like fibrillar
aggregates. Elucidating the fibril formation mechanism is critical for understanding Huntington's disease
pathology and for developing novel therapeutic strategies. Here, we performed systematic experimental and
theoretical studies to examine the self-assembly of an aggregation-prone N-terminal HTT exon-1 fragment
with 49 glutamines (Ex1Q49). Using high-resolution imaging techniques such as electron microscopy and
atomic force microscopy, we show that Ex1Q49 fragments in cell-free assays spontaneously convert into
large, highly complex bundles of amyloid fibrils with multiple ends and fibril branching points. Furthermore, we
present experimental evidence that two nucleation mechanisms control spontaneous Ex1Q49 fibrillogenesis:
(1) a relatively slow primary fibril-independent nucleation process, which involves the spontaneous formation
of aggregation-competent fibrillary structures, and (2) a fast secondary fibril-dependent nucleation process, which
involves nucleatedbranching andpromotes the rapid assembly of highly complex fibril bundleswithmultiple ends.
The proposed aggregation mechanism is supported by studies with the small molecule O4, which perturbs early
events in the aggregation cascade and delays Ex1Q49 fibril assembly, comprehensive mathematical and
computational modeling studies, and seeding experimentswith small, preformed fibrillar Ex1Q49 aggregates that
promote the assembly of amyloid fibrils. Together, our results suggest that nucleated branching in vitro plays a
critical role in the formation of complex fibrillar HTT exon-1 aggregates with multiple ends.
© 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Proteins with diverse sequences, structures and
functions can spontaneously self-assemble into mor-
phologically similar insoluble protein aggregates, often
referred to as amyloid [1–3]. Amyloid aggregates are
highly stable fibrillar structures with a characteristic
cross-β-sheet conformation [4]. They are associated
with a wide range of neurodegenerative and localizedthors. Published by Elsevier Ltd. This is a
g/licenses/by-nc-nd/4.0/).non-neuropathic diseases [5–7]. However, they also
play important roles in normal cellular processes like
the biogenesis of melanosomes or the regulation of
translation in yeast [8,9].
The process of fibril self-assembly can be divided
into two phases: a lag phasewhere little or no fibrils are
formed and a fibril growth phase where a large
increase of fibril mass is observed [10]. Theoretical
models typically describe fibrillogenesis as dependingn open access article under the CC BY-NC-ND license
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possibly secondary processes [10–14]. The formation
of an initial “nucleus” is regarded as the rate-limiting
step in amyloid formation. The nucleus is currently
thought to be a kinetically unstable oligomer of low
abundance spontaneously forming from interacting
monomers during the lag phase [12]. Once assem-
bled, it is assumed to grow into large, highly stable
β-sheet-rich structures with a fibrillary morphology by
monomer addition. The characteristic fibril growth
profile observed for many amyloidogenic polypeptides
reflects the greater ease of addition of monomers onto
existing β-sheet-rich aggregates compared to the
de novo formation of new amyloidogenic oligomers
(nuclei) from monomers through primary nucleation
[14]. Several recent studies have demonstrated
the involvement of secondary processes such as
fragmentation [15,16], secondary nucleation, i.e. nu-
cleation at the surface of an existing fibril [17–19] or
fibril branching [20] in the aggregation of amyloido-
genic polypeptides, and have shown that theoretical
models with a single nucleation mechanism cannot
fully explain the aggregation process under different
conditions (e.g., Refs. [15,17–19,21–23].).
Evidence has been provided that N-terminal
Huntingtin exon-1 (HTTex1) fragments with pathogen-
ic polyglutamine (polyQ) tracts spontaneously self-
assemble into insoluble aggregates with fibrillar
morphology [24–30]. This indicates that formation of
amyloid-like HTTex1 aggregates is mechanistically
similar to α-synuclein or amyloid-β aggregation ob-
served in various model systems [26]. Spontaneous
HTTex1 fibrillogenesis critically depends on the length
of the polyQ tract and on protein concentration and
time [25]. It can be stimulated by preformed fibrils,
hinting that it is dominated by a nucleation-dependent
aggregation mechanism [25]. Based on studies with
simple polyQpeptides [31], it was initially assumed that
a single, fibril-independent primary nucleation step is
critical for HTTex1 polymerization in vitro and in vivo.
However, studies with full-length and C-terminally
truncated HTTex1 fragments provided experimental
evidence that the aggregation mechanism is indeed
much more complex, involving the formation of non-
fibrillar and fibrillar oligomers followed by the assembly
of large fibrillary structures [27,32–38]. Previous
investigations indicate that HTTex1 fragments are
produced by abnormal splicing in HD patients and
transgenic animals [39], supporting their potential
relevance in disease. A better understanding of the
assembly cascade of HTTex1 fragments with patho-
genic polyQ tracts therefore might provide important
insights into pathogenesis.
In the present study, we have systematically
analyzed the aggregation mechanism of a disease-
relevant HTTex1 fragment with 49 glutamines
(Ex1Q49), using biochemical, biophysical and com-
putational methods. We show that self-assembly of
Ex1Q49 fragments released by proteolytic cleavagefrom soluble glutathione S-transferase (GST) fusions
results in the formation of large, highly complex
bundles of Ex1Q49 fibrils with multiple ends. Further-
more, we present evidence that Ex1Q49 aggregation is
controlled by a double-nucleation mechanism. Initially,
a primary fibril-independent nucleation process leading
to the formation of aggregation-competent structures
dominates Ex1Q49 aggregation. It is followed by a
rapid secondary fibril-dependent nucleation process,
which involves in particular the growth of new branches
from the surface of existing fibrils which remain
attached to the parent fibril; we denote this process
as nucleated fibril branching. Perturbation studies with
the small molecule O4 that directly targets Ex1Q49
polypeptides and mathematical modeling of time-
resolved Ex1Q49 aggregation data support our exper-
imental results that the observed fibrillar Ex1Q49
bundles grow by a nucleated branching mechanism.
Furthermore, seeding experiments with small pre-
formed Ex1Q49 fibrils substantiate the view that
nucleated branching, instead of lateral aggregation
of fibrils, is the reason for the observed formation of
large, complex fibril bundles. The implications of these
mechanistic investigations for the pathogenesis of HD
are discussed.
Results
Ex1Q49 spontaneously self-assembles into large,
SDS-stable protein aggregates in cell-free assays
To study the kinetics of polyQ-mediated HTT exon-1
(HTTex1) aggregation and the nature of the nucleating
aggregate species, a cell-free aggregation assay was
establishedwhichallows for thesystematic investigation
of aggregation reactions in a time- and concentration-
dependent manner under non-denaturing conditions
[40]. A purified, soluble GST HTT exon-1 fusion
protein with 49 glutamines (GST–Ex1Q49) was
produced and purified from Escherichia coli protein
extracts as the starting material for the investigation
of spontaneous Ex1Q49 aggregation in vitro (Fig. 1a).
It migrates at ~60 kDa in denaturating SDS gels
(Fig. S1a). Analysis by gel filtration under non-
denaturating conditions, however, revealed that the
fusion protein is a stable, soluble oligomer with a size of
~500 kDa (Fig. S1b).
Next, the purified GST–Ex1Q49 fusion protein
(2 μM) was treated with the sequence-specific Pre-
Scission protease (PP) in order to release aggregation-
prone Ex1Q49 fragments (Figs. 1a and S1c). Samples
were incubated at 20 °C in microtiter plates and the
formation of stable Ex1Q49 protein aggregates was
monitored over time by a denaturating membrane filter
retardation assay (FRA) using the anti-HTT antibody
CAG53b. This antibody specifically recognizes amino
acids in the conserved N17 domain as well as the
proline-rich region in HTTex1 (Figs. 1a and S1d).
Fig. 1. Spontaneous formation of large SDS-resistant Ex1Q49 aggregates in vitro. (a) Schematic representation of
GST–Ex1Q49 fusion protein and epitope binding sites of monoclonal and polyclonal antibodies used. (b) Time-resolved
analysis of SDS-resistant Ex1Q49 aggregates by FRA. Ex1Q49 aggregation was initiated by proteolytic cleavage of
GST–Ex1Q49 fusion protein (2 μM) with PP. Aggregates retained on filter membranes were detected using the polyclonal
anti-HTT antibody CAG53b. (c) Quantification of spontaneously formed Ex1Q49 aggregates by FRAs and ThT assays
(solid line, mean ± SD, n = 4; dashed line, mean ± SD, n = 3). GST–Ex1Q49 fusion protein (2 μM) was incubated with PP
at 20 °C. The highest signals were set to 100%. (d) Analysis of Ex1Q49 aggregation (20.9 μM) by DLS. Left panel: particle
size distribution prior (0 h) and after PP addition (at 0.5 and 3 h). Right panel: color-coded particle diameter distribution
over time. Shown are the results for one representative experiment out of four. (e) Analysis of GST–Ex1Q49 (2 μM)
aggregation reactions by AFM at different time points after addition of PP. (f) Analysis of Ex1Q49 fibril bundles by TEM
revealed potential fibril branching points, which are indicated by triangles. Ex1Q49 aggregates were examined 8 h after
addition of PP to GST–Ex1Q49 fusion protein (2 μM). Samples were incubated at 20 °C.
1727Mutant Huntingtin Exon-1 FibrillogenesisPrevious studies revealed that denaturating FRAs can
be applied to specifically quantify the abundance of
SDS-stable, fibrillar HTTex1 aggregates with lengths
N0.2 μm in complex protein solutions, whilemonomers
and small oligomeric structures are not detected [25].We found that PP treatment disintegrates soluble
GST–Ex1Q49 oligomers and results in the rapid
formation of SDS- and heat-stable Ex1Q49 protein
aggregates, which are detectable after a short lag
phase of ~2 h (Fig. 1b and c). This confirms previous
1728 Mutant Huntingtin Exon-1 Fibrillogenesisobservations that HTTex1 fragments with pathogenic
polyQ tracts rapidly self-assemble into highly stable
protein aggregates, once they are released from GST
fusion proteins by proteolytic cleavage [25,41]. As
expected, no SDS-stable Ex1Q49 aggregates were
detected by FRAs in the absence of PP (Fig. 1b). The
cleavage of the GST–Ex1Q49 fusion protein with PP
was confirmed by SDS-PAGE and immunoblotting
(Fig. S1e).
As previous studies indicate that insoluble polyQ
protein aggregates are β-sheet-rich structures [42], we
examined the formation of Ex1Q49 aggregates using a
Thioflavin T (ThT) dye-binding assay commonly used
to quantify cross-β-sheet amyloid [43]. We found that
aggregates detected by FRAs and ThT-reactive
aggregates form at similar rates (Fig. 1c), indicating
that the observed aggregates by FRAs are β-sheet-rich
structures.
We also addressed the question of whether the
kinetics of spontaneous Ex1Q49 aggregation in cell-
free assays is influenced by agitation. Previous
investigations have demonstrated that shaking of
samples with amyloidogenic polypeptides stimulates
amyloid growth due to fibril breakage and growth at
the ends of newly formed fibrils [15,16], suggesting
that also the aggregation of Ex1Q49 might be
influenced by mechanical forces. Aggregation reac-
tions with GST–Ex1Q49 fusion protein and PP were
systematically analyzed with (300 and 600 rpm) and
without agitation using FRAs. We found that shaking
of samples does not promote spontaneous Ex1Q49
fibril assembly in vitro (Fig. S2a). In particular, we did
not observe an impairment of Ex1Q49 aggregation
without agitation. The kinetics of the spontaneous
process remained also unaltered when increasing
concentrations of additional proteins such as bovine
serum albumin were added to the reactions (Fig. S2b),
indicating that this process is very robust and cannot
be easily influenced.
Finally, we examined the kinetics of spontaneous
Ex1Q49 aggregation by dynamic light scattering
(DLS), which provides size distribution profiles of
aggregating protein molecules [44,45]. For DLS
analysis, a higher concentration of GST–Ex1Q49
fusion protein (20.9 μM) was needed than for FRA
analysis (2 μM; Fig. 1b and c). From the autocorrela-
tion curves, the size distribution was computed
(Fig. 1d). Proteolytic cleavage of GST–Ex1Q49
oligomers with a diameter of 19.27 ± 1.28 nm (n = 4)
resulted in the release of smaller particles (GST and
Ex1Q49molecules)with a size distribution that peaked
at 10.89 ± 0.92 nm (n = 4). This is larger than the
previously reported radii for GST in solution (4.2 nm,
hydrodynamic radius) and Ex1Q49 (~2.5 nm, radius
of gyration), respectively [46,47].GSThasbeenshown
to dimerize in solution [47]. The observed diameter
could therefore be explained from a mixed population
of GST and Ex1Q49 oligomers. After a lag phase of
~1 h, large particles (diameter N700 nm) rapidlystarted to appear, indicating the spontaneous forma-
tion of Ex1Q49 aggregates. After 2 h, the size
distribution reached a steady state and peaked at
1204 ± 93 nm (n = 4). Thus, our DLS studies confirm
the results obtained by FRAs (Fig. 1c) and demon-
strate that large Ex1Q49 aggregates are rapidly
formed from monomers or very small oligomers that
are released from larger GST–Ex1Q49 oligomers by
proteolytic cleavage (Fig. 1d).
Ex1Q49 spontaneously forms bundles of highly
connected amyloid fibrils with multiple ends
Our studies indicate that Ex1Q49 fragments
rapidly self-assemble into large, highly stable protein
aggregates after a short lag phase (Fig. 1b–d). To
investigate the morphology of these structures, we
analyzed the time-dependent formation of Ex1Q49
aggregates by atomic force microscopy (AFM). We
observed that soluble, uncleaved GST–Ex1Q49 olig-
omers are very small spherical particles (Fig. 1e),
confirming previous reports [41,48]. However, in
PP-treated samples, bundles of Ex1Q49 fibrils with
multiple ends were detectable. These structures
increased in their height, width and length over time
(Figs. 1e, S3a and b). This suggests that β-sheet-rich,
amyloidogenic Ex1Q49 aggregates grow in vitro by
fibril branching, a secondary process that was previ-
ously described for the peptide hormone glucagon [20].
To substantiate these observations, aggregation
reactions with GST–Ex1Q49 and PP were systemat-
ically analyzed by transmission electron microscopy
(TEM). These studies confirmed that Ex1Q49 mole-
cules spontaneously self-assemble into complex
fibrillar bundles with multiple ends (Fig. 1f). Strikingly,
the analysis by EM also revealed multiple branching
points in Ex1Q49 fibrils (see white triangles in Fig. 1f
and red arrows in Fig. S3c), suggesting that the
observed fibril ends in bundles could be formed by
nucleated fibril branching rather than a lateral associ-
ation of initially formed fibrils.
Epitope-specific antibodies reveal conformational
changes in soluble aggregation-prone Ex1Q49
molecules
To study fibril assembly of Ex1Q49 molecules over
time under non-denaturating conditions, dot blot
assays (DBAs) with epitope-specific anti-HTT antibod-
ies were performed [49]. We initially examined the
time-dependent aggregation of Ex1Q49 using the anti-
polyQ antibodies MW1 and 3B5H10 (Fig. 1a), both of
which recognize short polyQ epitopes in soluble HTT
proteins [50–52].We found that both antibodies readily
recognize uncleaved GST–Ex1Q49 fusion protein
(Fig. 2a and b), indicating that linear polyQ epitopes
are exposed on the surface of GST–Ex1Q49 oligo-
mers (Fig. S1b). Proteolytic cleavage of GST–Ex1Q49
with PP, however, caused a time-dependent decrease
Fig. 2. Investigation of Ex1Q49 aggregation under non-denaturing conditions using epitope-specific antibodies. (a) Analysis
of spontaneous Ex1Q49 (2 μM) aggregation by non-denaturing DBAs. Samples were spotted onto a nitrocellulose membrane;
retained Ex1Q49 protein was detected using the epitope-specific antibodies MW1, 3B5H10 or MW8. (b) Quantification of
antibody immunoreactivity. The highest signals were set to 100%.
1729Mutant Huntingtin Exon-1 Fibrillogenesisof antibody binding to the polyQ tract in Ex1Q49
fragments (Fig. 2a and b), indicating that the polyQ
epitopes are less accessible for antibody binding in
released Ex1Q49 fragments. We observed a more
rapid loss of immunoreactivity with the MW1 than with
the 3B5H10antibody, indicating that theMW1-reactive
polyQ conformation is accessible for antibody binding
for a shorter time. We found that the rate of
GST–Ex1Q49 fusion protein cleavage detected by
SDS-PAGE and immunoblotting was similar to the
rate of MW1-immunoreactivity loss observed by
DBAs (Fig. S4a), indicating that proteolytic cleavage
of the GST fusion protein is responsible for the
time-dependent decrease in MW1 immunoreactivity.
Thus, our studies with DBAs suggest that Ex1Q49
fragments, when released from GST fusions by
proteolytic cleavage, undergo a rapid conformational
rearrangement, which preventsMW1antibody binding.
This conformational change is likely to occur in soluble
Ex1Q49 molecules and precedes spontaneous
amyloid polymerization.
In comparison to the time-dependent decrease in
MW1 immunoreactivity, the decrease of 3B5H10
immunoreactivity was shifted to later time points
(Fig. 2a and b). This suggests that this antibody
binds to monomers or small, soluble Ex1Q49 oligo-
mers but not to large β-sheet-rich amyloid fibrils
that appear later in aggregation reactions (Fig. 1c–f).
To address this question in more detail, preformed
fibrillar Ex1Q49 aggregates were also systematically
analyzed with DBAs in independent experiments
(Fig. S4b). We found that the 3B5H10 antibody did
not recognize these structures, confirming our hypoth-
esis that it preferentially binds to soluble, non-fibrillar
Ex1Q49 structures.
Using DBAs, we finally examined the binding of
the epitope-specific antibody MW8 to aggregating
Ex1Q49 molecules. This antibody recognizes aC-terminal proline-rich region in the Ex1Q49 fragment
(Fig. 1a). We found that MW8 weakly binds to
uncleaved GST–Ex1Q49 fusion protein in DBAs.
Treatment of the fusion protein with PP further
decreased MW8 immunoreactivity (Fig. 2a and b),
suggesting that the epitope is less accessible for
antibody binding in released, aggregation-competent
Ex1Q49 molecules. However, it is also possible that
the time-dependent decrease in immunoreactivity is
due to an antibody avidity effect, when the spherical
GST–Ex1Q49 oligomers are disintegrated upon PP
treatment. After a lag phase of ~2 h, however, a steep
increase of MW8 immunoreactivity was observed
(Fig. 2b), indicating that the antibody efficiently binds
to spontaneously formed fibrillar Ex1Q49 aggregates
(Fig. 1e). A similar result was observed when Ex1Q49
aggregation reactions were analyzed in a time-
dependent manner with denaturating FRAs that
specifically detect large SDS-stable aggregates
(Fig. S4c), confirming that the MW8 antibody prefer-
entially recognizes β-sheet-rich fibrillar structures in
complex aggregation reactions.
The small molecule O4 delays spontaneous
Ex1Q49 polymerization in cell-free assays
To study the mechanism of Ex1Q49 aggregation
and to perturb specific microscopic steps in the protein
assembly process, we searched for small molecules
that can influence amyloid aggregation. We selected
four previously reported amyloid-binding compounds,
namely curcumin (Curc), methylene blue (MB),
PGL-34 and O4 (Table S1) and systematically tested
their activity in the established Ex1Q49 aggregation
assay. We found that only the compound O4 affected
Ex1Q49 aggregation in a concentration-dependent
manner (Figs. 3a, b and S5a–c), indicating that it
directly targets aggregation-prone Ex1Q49molecules.
Fig. 3. The small molecule O4 extends the lag phase in the Ex1Q49 aggregation cascade. (a) Chemical structure of O4.
(b) Analysis of spontaneous Ex1Q49 aggregation in the presence and absence of O4 by FRA. GST–Ex1Q49 fusion
protein (2 μM) was incubated with PP and different concentrations of O4 at 20 °C. SDS- and heat-stable aggregates
retained on filter membranes were immunodetected with CAG53b antibody. (c) Analysis of Ex1Q49 aggregation reactions
with DBAs using the monoclonal antibodies MW1, 3B5H10 and MW8. GST–Ex1Q49 (2 μM) fusion protein was incubated
with PP and O4 (2 μM) at 20 °C. (d–f) Quantification of dot blot results shown in panel c.
1730 Mutant Huntingtin Exon-1 FibrillogenesisSDS-PAGE and immunoblotting confirmed that the
effect of O4 on Ex1Q49 aggregation is not due to
inhibition of PP cleavage (Fig. S5d).
More detailed investigations revealed that O4
significantly extends the lag phase of Ex1Q49
aggregation in a concentration-dependent manner
(Fig. S5e), but does not significantly affect the maximal
fibril growth rate. A similar effect of the compound was
observed with DLS (Fig. S5f), indicating that O4
perturbs early rather than late events in the Ex1Q49
aggregation cascade. Furthermore, studies by AFM
and TEM revealed that in the presence of O4, typical
fibril bundles with multiple ends are detectable
(Fig. S5g), indicating that the compound does not
alter the putative branching process or impair Ex1Q49
fibril growth.We also examined the effect of O4 on spontaneous
Ex1Q49 aggregation using DBAs (Fig. 3c–f). We
observed that the time-dependent decrease of
3B5H10 immunoreactivity is significantly delayed
upon compound treatment, while no compound effect
was observed on the decrease of MW1 immunoreac-
tivity. This suggests that O4 preferentially targets
soluble, 3B5H10-reactive Ex1Q49 molecules that are
released from GST fusions and delays their incorpo-
ration into fibrillar aggregates. Strikingly, a delay in the
increase of MW8 immunoreactivity was also observed
(Fig. 3f), suggesting a causal relationship between
disappearance of 3B5H10- and appearance of
MW8-reactive Ex1Q49 molecules in spontaneous
aggregation reactions. Together, these results support
the data obtained byFRAsandDLS (Figs. 3b andS5f).
1731Mutant Huntingtin Exon-1 FibrillogenesisMolecular dynamic simulations indicate that O4
directly targets HTTex1 molecules with expanded
polyQ tracts and alters their conformation
We employed computational approaches for
an assessment of how O4 might interact with
aggregation-prone HTTex1 molecules, using two
in silico generated structures: (i) the most represen-
tative conformation of a β-sheet-rich HTT exon-1
protein with 47 glutamines (Ex1Q47) [53] and (ii) a
structure of Ex1Q46 with lower β-sheet content from
a different study [54]. These proteins are similar
in size to the Ex1Q49 fragment that was used in our
experimental studies.
We first performed systematic docking calculations
for Ex1Q47 with AutodockVina using both rigid and
flexible approaches and different grid sizes [55]. We
then selected seven possible binding sites, based on
their geometrical differences and their calculated
docking affinities, which cover a range from −7.6 to
−10.4 kcal/mol (Table S2). To better discriminate
between the docking conformations and to takeFig. 4. The compound O4 perturbs the structure of an N-te
docking and QM/MM MD studies predict that O4 binds to β-sh
binding motif: A7, purple; D1, orange; A5, yellow; and A8, cyan
regions: N-terminus in blue, polyQ in red, polyP in gray and the
One of the most favored binding motifs, A7, is displayed in more
Ex1Q47 are shown. (b, c) O4 alters the β-sheet structure of Ex1
simulations): (b) reference system without O4 and (c) Ex1Q47 i
Secondary structure propensity per residue for the MD simulati
O4. The decrease in β-sheet content in Ex1Q47 due to O4 binexplicitly into account solvent and dynamics effects,
we performed quantum mechanics/molecular me-
chanics molecular dynamics (QM/MM MD) simula-
tions (seeMaterials andMethods for details) with these
seven binding sites. The analysis of the QM energies
from the QM/MM MDs indicates that O4 binding to
positions A7 and D1 is more favorable, followed by A5
and A8 (Table S2). Contacts between O4 and the
polyQ region were found for all binding positions,
including those less favored, which is not surprising
given the size of this region. Interestingly, the
interaction motifs of O4 with Ex1Q47 on the preferred
binding sites A7 and D1 suggested that the ligand
associates not only with the β-sheet-rich polyQ tract
but alsowith other β-sheet regions at the N-terminal 17
amino acids in Ex1Q47 as well as the C-terminus
(Fig. 4a and Table S2). The N-terminal residues in
HTTex1 were previously shown to promote protein
aggregation in cell-free assays [28,56], substantiating
our hypothesis that direct binding of O4 to soluble,
aggregation-prone Ex1Q49 molecules might slow
down the formation of fibrillar aggregates (Fig. 3c–f).rminal, β-sheet-rich Ex1Q47 fragment. (a) Computational
eet-rich Ex1Q47 molecules. O4 is colored according to the
(see also Fig. S6). Different colors are used for the Ex1Q47
mixed region including the C-terminus is shown in green.
detail. The residues within a 3-Å distance between O4 and
Q47monomers. Representative structures of Ex1Q47 (MD
n the Ex1Q47–O4 system (binding site A7, O4 omitted). (d)
ons of Ex1Q47 without (left) and with (right, binding site A7)
ding is particularly evident in residues 9–13 and 52–56.
1732 Mutant Huntingtin Exon-1 FibrillogenesisNext, to examine whether O4 binding influences the
β-sheet content in Ex1Q47, we performed additional
molecular dynamics (MD) simulations, focusing in
this case, on four putative compound bindings sites
(e.g., A7, D1, A5 and A8) in the Ex1Q47 protein
(Table S2). These simulations indicate that O4 binding
promotes a time-dependent disassembly of the initially
available β-sheet structure in Ex1Q47 (Figs. 4b–d, S6
and Movies S1 and S2). For instance, the β-sheet
content in Ex1Q47was found to be 12% in simulations
without O4 (Table S3). With the only exception of A8,
where it remains constant, this value decreases to 9%,
7% and 2% for A5, D1 and A7, respectively, in the
presence of O4 (Table S3 and Fig. S8). In the absence
of O4, the initial four β-strands remain unchanged
during the entire simulation (Fig. 4d). In comparison,
an almost complete loss of the four β-strands was
observed when the binding site A7 was analyzed in
the presence of O4 (Figs. 4d and S6). Similarly, the
β-strand covering residues 9–13 and 52–56 in
Ex1Q47 were lost with the compound in the context
of the binding site D1 (Fig. S8). In the case of A5, the
β-strands are not completely lost in the presence of
O4 but residues 9–13, 52–56 and 87–91 explore coil
and turn conformations for more than half of the
simulations time (Fig. S8).
To investigate whether the same compound effects
can also be observed with pathogenic HTTex1
conformations having a lower β-sheet content, we
performed two additional independent simulationswith
an Ex1Q46 structure, complexed with O4 or without
the compound. The MD simulations performed with
Ex1Q47 suggested that, after O4 destroys the β-
sheets, it starts exploring the surface of Ex1Q47
without any preferred binding site (Fig. S10). There-
fore, and due to the relatively lowβ-sheet content of the
Ex1Q46 structure, weused an initial geometry inwhich
O4 was placed within 4 Å of the surface-exposed side
of the β-strands of the Ex1Q46 conformer. As with
Ex1Q47, the simulations with Ex1Q46 suggested that
O4 binding promotes a time-dependent disassembly
of the initial β-sheet structure (Figs S7 and S9). For
Ex1Q46, the β-sheet propensity decreases by about
3% in the presence of O4 in both replicas of the
simulations (Table S3).
The inter-residue contact maps also evidence a
decrease in the β-sheet content in both Ex1Q47 and
Ex1Q46. This can be seen in the patterns for the
interactions between residues 9–12 and 42–45 of
Ex1Q47 (Fig. S12) and residues 24–33 of Ex1Q46
(Fig. S13). Beyond the β-sheet region, O4 also
impacts the structures of both proteins by promoting
more open conformations with less inter residue
contacts. For example, the interactions between
residues 70–80 and 85–100 are weaker in A5, A7,
A8 and D1 with respect to Ex1Q47 without ligand
(Fig. S12). Since the initial structures of Ex1Q46 are
highly disordered, the contact maps for this protein
are less revealing than for Ex1Q47. Nevertheless,for the MD simulations with Ex1Q46, the impact of
O4 is evident by the loss of the interactions between
residues 32–40 and 52–60 (Fig. S13).
Taken together, the simulations suggest that O4
promotes a binding-dependent destruction of the
β-strands in Ex1Q47 and Ex1Q46. Interestingly, O4
does this without having a conserved binding site in
the HTTex1 protein. Thus, after the β-strands are
destroyed, the binding of O4 to HTTex1 becomes
weak and O4 starts exploring the protein surface
(Fig. S11). This potentially might impair the formation
of newly formed β-sheet-rich structures in Ex1Q49
molecules, which are released in our experimental
studies by proteolytic cleavage of GST–Ex1Q49
fusion proteins (Fig. 1a–c).
A theoretical nucleated branching model correctly
reproduces the effect of O4 on spontaneous
Ex1Q49 aggregation
Theexperimental results suggest that fibril branching
could be responsible for the rapid formation of Ex1Q49
fibril bundles in cell-free assays (Fig. 1f). To better
understand the molecular events underlying sponta-
neous Ex1Q49 fibrillogenesis, we next developed a
theoretical aggregation model that, besides primary
nucleation and templated polymerization as an elon-
gation process [11,12,15], also includes nucleated fibril
branching, a special form of secondary nucleation (see
Materials and Methods and Supplemental Methods,
Kinetic modeling of Ex1Q49 aggregation). Previously,
various theoretical models have been reported that
include primary nucleation, templated fibril polymeri-
zation, and secondary processes [15,16,18]. However,
none of these models explicitly accounts for the
fate of newly nucleated branches that remain
attached to mother fibrils as observed for instance for
glucagon fibrils [20]. Sincewe did not observe an effect
of agitation in our experimental studies (Fig. S2a),
fragmentation was not included in our model.
The theoretical Ex1Q49 aggregation model with
nucleated branching describes four processes: (i) the
release of the aggregation-prone Ex1Q49 molecules
by proteolytic cleavage of GST–Ex1Q49 through the
action of PP; (ii) the initial formation of a growth nucleus
via primary nucleation (Fig. 5a green arrows; size
parameter nc and rate constants kn1 and k−n1,); (iii) fibril
elongation growth by addition of Ex1Q49 monomers
via templated polymerization (Fig. 5a, red arrows, rate
constant k1); and (iv) secondary nucleation at the
surface of Ex1Q49 fibrils, resulting in the formation of
multiple interconnected growing fibril branches (Fig. 5a
blue arrows, order nb and rate constant kb). The last
process is denoted as nucleated branching. Com-
pared to previous models with secondary nucleation
[21], our model assumes that each protein unit only
nucleates a limited number of branches and more
importantly considers the fate of the newly nucleated
fibrils that remain attached to the mother fibril. The
Fig. 5. The theoretical model with nucleated branching correctly reproduces the effect of O4 on spontaneous Ex1Q49
aggregation. (a) Schematic for a nucleated branching model. After PP cleavage of GST, Ex1Q49 can spontaneously
nucleate and switch to an active aggregation-prone conformation with rate constant kn1. Fibrils can then elongate by
addition of monomers in templated polymerization, rate constant k1. In addition, a nucleated branching reaction can occur
with rate constant kb. This creates a new growing fibril. If the branching rate constant kb = 0, the model reduces to a linear
templated polymerization model. (b) In the model, O4 can either decrease the primary nucleation rate constant kn1 (green),
the nucleated branching rate constant kb (blue), or the templated polymerization rate constant k1 (red) in a concentration-
dependent way. (c) Simulated FRA data from the model with nucleated branching (nc = 1 and nb = 1) without (solid lines)
and with O4 (dashed lines). The experimental data (symbols, mean ± SD) show aggregation for two different initial
GST–Ex1Q49 concentrations and three different O4 concentrations as indicated using the CAG53b antibody.
Experimental data and model were normalized to maximal value of the control with 2 μM initial GST–Ex1Q49. Parameter
ranges and values are listed in Tables S4 and S5. (d) Differences in the corrected Akaike information criterion (AICc)
with respect to the best-fitting model for three different O4-mediated inhibition scenarios (shown in colored symbols) and
the model without nucleated branching (kb = 0, circle) or with nucleated branching (kb N 0, squares) as well as different
values of the nucleus size nc and the branching order nb. Models were fitted to the experimental data from panel c (see
Supplemental Data). A large value indicates a less good fit compared to the best model.
1733Mutant Huntingtin Exon-1 Fibrillogenesislatter modification is necessary to describe the large
complex bundles observed in vitro and the effect of
perturbations on their size. Since spontaneously
formed fibrillar Ex1Q49 aggregates are very stable
structures (Fig. 1b and c), our theoretical modelassumes irreversible reactions for templated polymer-
ization and nucleated branching (see Materials and
Methods and Supplemental Methods Kinetic modeling
of Ex1Q49 aggregation). To compare the model to the
experimental FRA data, we developed a normalization
1734 Mutant Huntingtin Exon-1 Fibrillogenesisprocedure and characterized the initial PP cleavage
reaction (seeMaterials andMethodsandFig. S14a–c).
Since the FRA assay only detects Ex1Q49 fibrils
when they are SDS-stable and have a length of
N0.2 μm [40], we used a size threshold for aggregate
detection (Cmin, see Supplemental Methods, Eqs.
S32–S33) estimated together with the kinetic model
parameters.
Our experimental studies indicate that O4 treat-
ment delays the lag phase of spontaneous Ex1Q49
aggregation in a concentration-dependent manner,
while it does not significantly influence the more
rapid amyloid growth phase (Fig. 3b). Previous
studies provide evidence that various microscopic
processes like primary and secondary nucleation and
even fibril growth can occur during the lag phase of
spontaneous aggregation reactions [57], suggesting
that O4 might interfere with different mechanisms
active in this phase of aggregate formation. We next
asked whether theoretical models with or without
nucleated branching (Fig. 5a) can describe the
observed compound effects in our experiments
(Fig. 3b), when assuming that the compound inhibits
either primary nucleation, templated polymerization or
nucleated branching (Fig. 5b). We fitted the theoretical
models that either include or lack nucleated branching
to Ex1Q49 aggregation data that were obtained in the
presence and absence of O4 at different initial
concentrations of GST–Ex1Q49 (see Fig. S14;
Materials and Methods; Supplemental Methods,
Fitting of HTTex1 kinetic models to data and Tables
S4 andS5). Spontaneous aggregation of Ex1Q49was
measured in a time-dependent manner by denaturat-
ing FRAs using theCAG53b antibody (Figs. 1b and 5c,
symbols). For all simulations, we assumed that
the nucleus size is similar for both primary nucleation
and nucleated branching, nc = nb. Models where
nc ≠ nb gave less or equally good fits. By systemati-
cally varying the nucleus size nc, we found that the
experimental data are best reproduced by the model
with nucleated branching and a nucleus of size nc = 1,
independent of the assumed inhibiting mode of O4
(Fig. 5c, lines and S15a-b, lines). The distinction
was made according to the corrected Akaike informa-
tion criterion (Fig. 5d, green, red and blue squares for
nc = 1). In contrast, the models without nucleated
branching (kb = 0) failed to reproduce thedata (Fig. 5d,
green and red circles and S15c). The reason is that
when sufficient fibrils are formed at the end of the lag
phase, the positive feedback mediated by nucleated
branching overcomes the effect of O4. This process
is independent of the specific mechanism by which
O4 inhibits aggregation. Together, these results
indicate that the nucleated branching process in
theoretical models (Fig. 5a) is required to describe
the experimental data. Furthermore, they suggest that
the perturbation of different microscopic processes
(primary nucleation, nucleated branching or templated
polymerization) could be responsible for the observedextension of the lag phase when O4 is added to
spontaneous reactions (Fig. 3b).
Previous studies indicate that time-resolved aggre-
gation profiles obtained at various protein concentra-
tions are sufficient to distinguish between aggregation
mechanisms when the experimental data are globally
fitted to different theoretical aggregation models
[15,19]. One assumption in these studies was that the
aggregate detection assay (e.g., a ThT assay, [15]) can
monitor a very broad range of aggregate species
including very small structures such as dimers, trimers
and small oligomers as well as large fibrils consisting of
thousands of molecules. However, there is no clear
evidence that standard aggregate detection methods
like the ThT assay are sensitive enough to monitor the
very early aggregate species. The denaturating FRAs
applied in our study exclusively monitor the growth of
relatively large, SDS-stable Ex1Q49 aggregates [40].
Thus, as for the fitting of the models to the O4 data
(Fig. 5c), an aggregate size detection threshold was
applied when the theoretical aggregation models were
globally fitted to aggregation profiles obtained at
various GST–Ex1Q49 concentrations (Fig. S16a,
symbols). Under these assumptions, the generated
concentration-dependent data sets are not sufficient for
the prioritization of specific aggregation mechanisms
because theoretical models with andwithout branching
both can describe concentration-dependent aggrega-
tion data equally well (Figs S16a and b, filled symbols).
Under the assumption that the FRA method detects
large and very small Ex1Q49 protein assemblies,
however, the theoretical model with nucleated branch-
ing (Fig. 5a) indeed globally fits concentration-
dependent aggregation profiles significantly better
than the theoretical model without this process
(Figs S16b and c, open symbols). This means that a
detailed qualification of the microscopic processes
in the aggregation cascade is not possible when
theoretical models are fitted to simple concentration-
dependent aggregation data. Use of a perturbator
molecule like O4 provides critical experimental data
that enable meaningful distinctions of aggregation
mechanisms with theoretical models.
Taken together, our experimental and theoretical
studies with the small molecule O4 support the
hypothesis that nucleated branching shapes the
aggregation kinetics of Ex1Q49 and is likely to be
critical for the formation of large bundles observed by
AFM and TEM (Fig. 1e and f). All critical assumptions
for the theoretical modeling studies are summarized in
Fig. S17.
The theoretical nucleated branching model
predicts that O4 preferentially perturbs primary
nucleation in the Ex1Q49 aggregation cascade
Our MD simulation studies suggest that O4 treat-
ment perturbs the β-sheet structure in aggregation-
prone HTTex1 molecules (Fig. 4). This might impair
1735Mutant Huntingtin Exon-1 Fibrillogenesisprimary nucleation, a critical early step in the amyloid
polymerization cascade [57] and lead to an extension
of the lag phase in Ex1Q49 aggregation reactions
(Fig. 3b). Our theoretical studies suggest that addition
of O4 together with PP to Ex1Q49 aggregation
reactions might extend the lag phase because the
compound inhibits primary nucleation, templated
polymerization or nucleated branching (Figs. 5c–d
and S15a, b). We hypothesized that inhibition of
primary nucleation with O4 should have a different
effect on the length of the lag phase than inhibition of
nucleated branching or templated polymerization,
especially when the compound is added at later time
points to aggregation reactions. Indeed, the theoretical
aggregation model with nucleated branching predictsFig. 6. The theoretical model with nucleated branching indic
the aggregation of Ex1Q49 (2 μMGST–Ex1Q49) of the best-fit
primary nucleation for addition of 2 μM O4 at different time poi
the addition of 2 μM O4 at the indicated time points to the aggr
nucleated branching where O4 inhibits the nucleated branching
at the indicated time points to the aggregation of Ex1Q49 (2
where O4 inhibits the templated polymerization process. (d) GS
or presence of 2 μM O4 added together with PP (0 h), 30 min
FRAs and were immunodetected with CAG53b antibody. Datadifferent outcomes of such an experiment depending
on which microscopic process is inhibited by O4
(Fig. 6a–c). For example, if we consider an inhibition of
primary nucleation by O4, the model predicts that
addition of O4 after 2 h does not significantly influence
the lag phase. In contrast, in the cases where
nucleated branching or templated polymerization are
inhibited by O4, the model predicts a significant
extension of the lag phase, even when the compound
is added to reactions after 2 h (Fig. 6b and c). This can
be explained by the fact that primary nucleation is a
very early event in the aggregation cascade, whereas
nucleated branching and templated polymerization
occur later in the process. Thus, when primary
nucleation is perturbed, compound addition after 2 hates that O4 inhibits primary nucleation. (a) Simulations of
ting model from Fig. 5c–d in which O4 is assumed to inhibit
nts post-PP addition as indicated. (b) Predicted kinetics for
egation of Ex1Q49 (2 μM GST–Ex1Q49) in the model with
process. (c) Predicted kinetics for the addition of 2 μMO4
μM GST–Ex1Q49) in the model with nucleated branching
T–Ex1Q49 (2 μM) was incubated in the absence (control)
, 1 h, or 2 h post-PP addition. Aliquots were analyzed by
were normalized to the control value at 7 h.
1736 Mutant Huntingtin Exon-1 Fibrillogenesishas a weak effect on the length of the lag phase as
the GST cleavage (requires ~2 h, Fig. S1e) and
the primary nucleation process (requires ~10 min,
Table S4) are nearly complete after 2 h. However, in
scenarios where the compound perturbs nucleated
branching or templated polymerization, it can still
extend the lag phase in Ex1Q49 aggregation reactions.
Finally, we investigated experimentally whether the
addition of O4 at later time points influences the lag
phase in spontaneous Ex1Q49 aggregation reactions.
We found that the addition ofO4after 0.5, 1 or 2 h to the
fibril formation process was indeed less efficient in
extending the lag phase (Fig. 6d) than the addition
of the compound at t = 0 h together with PP. This
supports our hypothesis that O4 targets primary
nucleation events in the Ex1Q49 aggregation cascade.
Predicting the impact of seeding on spontaneous
Ex1Q49 aggregation
Preformed aggregated β-sheet-rich polypeptide
structures of varying sizes can act as nuclei or seeds
that potently stimulate the formation of fibrillar struc-
tures [58,59]. When they are added to aggregation
reactions at early time points, they efficiently shorten
the lag phase prior to the fibril growth phase [60]. We
first studied putative seeding effects of preformed
Ex1Q49 fibrils (seeds) on spontaneous HTTex1
aggregate formation using our theoretical model with
nucleated branching. The model predicts that the
addition of increasing amounts of seeds to aggregation
reactions causes a decrease in the lag phase without
affecting the rate of fibril formation (slope, Fig. 7a,
showing the percentage of protein bound in complexes
larger than the simulated seed size). Interestingly, we
found that the addition of seeds to reactions also
changes the predicted size distribution of Ex1Q49
aggregates. In Fig. 7b, we show the average size at
steady state, normalized to the average aggregate size
without seed addition (seed fraction = 0), as a function
of the seed fraction (Fig. 7b, red line). Strikingly, for
higher seed concentrations, the size of the predicted
Ex1Q49 fibrils was strongly decreased. Moreover, the
model predicts that high concentrations of seeds also
strongly decrease the average number of branches
per aggregate (Fig. 7b, blue line). This is due to the fact
that the only pathways for aggregate growth in the
theoretical model are templated polymerization and
nucleated branching and fibrils can only grow by
monomer addition. The seeds in the reaction compete
for a limited pool of monomers, which leads to the
formation of small aggregates when seed concentra-
tion is high, while large aggregates should form when
the concentration is low. For very low numbers of
seeds, we observed a small increase in aggregate size
and number of branches (Fig. 7a). The explanation for
this increase is that the added seeds outcompete
spontaneously formed nuclei for monomers and grow
more rapidly into larger fibrils.Preformed Ex1Q49 seeds shorten the onset
of spontaneous aggregate assembly in
a concentration-dependent manner
To study the impact of preformed Ex1Q49 seeds on
aggregate formation, we designed a FRET-based
HTTex1 aggregation assay. We first produced and
purified recombinant GST–HTTex1 fusion proteins,
which areC-terminally fused to the fluorescent proteins
CyPet or YPet (GST–Ex1Q48–CyPet or –YPet;
Fig. S18a and b). We hypothesized that these fusion
proteins, when co-incubated with PP, release
the aggregation-prone fragments Ex1Q48–CyPet
and –YPet that over time co-assemble into ordered
fibrillar aggregates and induce FRET (Fig. S18b).
First, we incubated different concentrations of
the fusion proteins GST–Ex1Q48–CyPet and –YPet
(1:1 molar ratio) in 384-well plates with PP and
quantified the appearance of FRET over time. We
observed a steep increase of FRET efficiency starting
after ~4–10 h, indicating that the proteolytically re-
leased HTTex1 fusion proteins, after a lag phase,
rapidly self-assemble into ordered, high-molecular
weight aggregates (Fig. S18c). The aggregation profile
is similar to the untagged Ex1Q49 proteins (Fig. 1c),
but the lag phase is extended due to the C-terminal
fluorescent tags that slow down spontaneous
aggregation.
Next, we produced well-defined, fibrillar Ex1Q49
aggregates to investigate them for their seeding activity
in the FRET-based HTTex1 aggregation assay. We
incubated GST–Ex1Q49 fusion protein for 24 h with
PP in order to obtain large fibrillar aggregates. The
generated fibrils were sonicated for 1 min on ice to
break the fibrils into small fibrillar seeds. Analysis
by AFM confirmed that small, fibrillar Ex1Q49 seeds
were obtained, while large bundles of HTTex1 fibrils
(N1 μm) were detectable in non-sonicated samples
(Fig. S18d).
Finally, we assessedwhether the sonicatedEx1Q49
aggregates influence the co-polymerization of the
reporter proteins Ex1Q48–CyPet and –YPet in FRET
assays. We treated a mixture (1:1 molar ratio) of the
fusion proteins GST–Ex1Q48–CyPet/–YPet with PP
and various concentrations (~1–100 nM) of preformed
sonicated Ex1Q49 seeds and analyzed the co-
polymerization of the released fusion proteins
Ex1Q48–CyPet/–YPet by quantification of FRET. We
observed a robust shortening of the lag phase when
preformed Ex1Q49 seeds were added to reactions
(Fig. 7c), indicating that these structures stimulate
Ex1Q48–CyPet/–YPet co-polymerization in a
concentration-dependent manner. With the highest
seed concentrations, the maximum FRET efficiency
was reached after ~4–5 h, with the lowest seed
concentrations after ~15 h. This supports our compu-
tational prediction for the untagged Ex1Q49 protein
that addition of preformed HTTex1 seeds shortens the
lag phase in amyloid formation reactions (Fig. 7a).
Fig. 7. A nucleated branching process correctly predicts the outcomes of HTTex1 seeding experiments. (a) Simulation of the
best-fittingmodel from Fig. 5c–dwith the addition of different fractions of seeds [Seed]/[GST–Ex1Q49]. Shown is the percentage
of protein bound in complexes above the seed size. In the simulations, we use dimers as seeds; this is the smallest possible
seed size. (b) Average simulated amyloid size (red line) and number of branches per aggregate (blue line) at steady state
for different fractions of seeds computed from Eq. S26, Supplement. All quantities are normalized to the values without seeds.
(c) Co-aggregation of the sensor proteins Ex1Q48–CyPet/–YPet was monitored in the presence of different concentrations of
sonicatedEx1Q49aggregates (seeds) byquantification of FRET for 50 h. Indicated seedconcentrations are equivalent to initially
applied monomer concentrations. The black arrow indicates the time point at which aggregation reactions were analyzed by
DBAs, FRAs and AFM shown in panels d and e. (d) AFM analysis of GST–Ex1Q48–CyPet/–YPet co-aggregates formed in the
absence and presence of different seed concentrations; samples were analyzed after 50 h. The scale bar represents 500 nm.
(e) Ex1Q48–CyPet/–YPet co-aggregates shown in panel d were analyzed by DBAs and FRAs. Proteins were detected using an
anti-GFP antibody.
1737Mutant Huntingtin Exon-1 FibrillogenesisHigh concentrations of preformed Ex1Q49 seeds
cause the formation of small fibrillar HTTex1
aggregates
Our theoretical investigations suggest that large
numbers of small, largely unbranched HTTex1 fibrilsshould be obtained when the spontaneous polymeri-
zation reactions are treated with very high concentra-
tions of preformed seeds (Fig. 7b). To validate this
prediction experimentally, we collected samples from
both seeded and non-seeded aggregation reactions
after 50 h (Fig. 7c, black arrow) and systematically
1738 Mutant Huntingtin Exon-1 Fibrillogenesisanalyzed them by AFM. We observed few, very large
bundles of HTTex1 fibrils in reactions that were treated
with low (1 nM) seed concentrations, while larger
numbers of smaller fibrils were observed with higher
seed concentrations (5–50 nM) (Fig. 7d). Interestingly,
a large number of very small HTTex1 fibrils with few or
no branches were detected when samples with very
high seed concentrations (100 nM) were analyzed,
confirming our theoretical predictions (Fig. 7b).
Together, these studies also indicate that the
complex bundles of HTTex1 fibrils observed in
spontaneous reactions (Fig. 1e) are indeed formed
from small seeds/nuclei through monomer addition
rather than the lateral association of fibrils. The analysis
of seeded aggregation reactions by FRET shows
that at high seed concentrations (10–100 nM), the
formation of HTTex1 fibrils is completed after 5–10 h
(Fig. 7c). As large numbers of small fibrils are detected
by AFM after 50 h in seeded reactions (Fig. 7d), we
assume that the small fibrils, which are already formed
after 5–10 h, have a very low tendency to co-aggregate
into large complex structures. In this way, our seeding
experiments strongly support a nucleated branching
mechanism in HTTex1 aggregation. Under the as-
sumption that HTTex1 fibrillogenesis is dominated by a
lateral association of small fibrils, we would expect that
an incubation period of 50 h with high seed concentra-
tions should lead to the assembly of large fibril bundles
(Fig. S19).
Finally, we analyzed all aggregation reactions after
50 h with FRAs, which exclusively detect large
(N0.2 μm), SDS-stable fibrillar HTTex1 aggregates
retained on cellulose acetate membranes [40]. In
reactions treated with high concentrations of Ex1Q49
seeds, no Ex1Q48–CyPet/–YPet aggregates were
detectable on filter membranes (Fig. 7e), while they
were readily observed in untreated reactions and
reactions treated with low seed concentrations. This
confirms the initial hypothesis that addition of high
seed concentrations to aggregation reactions leads
to the formation of many small HTTex1 aggregates
(Fig. 7b). In reactions treated with high seed concen-
trations, however, anti-HTT immunoreactivity was
detectable with DBAs (Fig. 7e), which detect both
soluble and aggregated HTTex1 proteins independent
of their size. Together, these investigations support the
observations made by AFM (Fig. 7d) that addition of
high concentrations of preformed Ex1Q49 seeds to
the Ex1Q48–CyPet/–YPet aggregation reactions
leads to the formation of small fibrillar structures,
whereas large, stable fibrils are obtained when low
concentrations of seeds are added to reactions.Discussion
In this study, we systematically investigated the
aggregation mechanism of a pathogenic N-terminal
HTTex1 fragment released from a soluble recombinantGST–Ex1Q49 fusion protein by site-specific proteolytic
cleavage using a combination of experimental and
computational methods. We were able to show that
Ex1Q49 molecules in vitro rapidly self-assemble into
very stable complex fibril bundles with multiple ends
and branching points. Furthermore, we obtained
experimental evidence that two nucleation processes
(primary nucleation and nucleated branching) and fibril
elongation characterize Ex1Q49 aggregation. An
earlier study already showed the importance of primary
nucleation for the aggregation of polyQ peptides [31].
Here, we present experimental and theoretical results
that three microscopic processes and in particular
nucleated fibril branching play a critical role in the
spontaneous assembly of Ex1Q49 aggregates.
To study the importance of nucleated branching in
the Ex1Q49 aggregation cascade, we developed a
theoretical aggregation model that includes primary
nucleation, nucleated branching and templated poly-
merization. Nucleated branching is a special case of
secondary nucleation, where new branches form on
the surface of already formed fibrils and remain
attached to them. This auto-catalytic pathway gener-
ates new extensions with a rate proportional to
the amount of existing aggregates (see, e.g., Refs.
[12,18,21–23,61]). Compared to previous theoretical
models (e.g., Refs. [14,16,17,21]), we specifically
account for the formation of new fibril ends by a
nucleated branching mechanism. This feature is
essential to describe the branched structures observed
in vitro (Fig. 1e) and the effect of seeds on the
aggregate size (Fig. 7b). We use multiple approaches,
such as chemical inhibitors and seeding, to identify via
global fitting the underlying aggregation mechanism
(for a summary of our overall strategy, see Fig. S17).
We found that time-resolved Ex1Q49 aggregation
profiles, generated in the presence and absence of
the aggregation-inhibiting small molecule O4, are
accounted for by the nucleated branching model.
Furthermore, this model correctly predicts the impact
of a delayed addition of O4 on Ex1Q49 aggregation
(Fig. 6) as well as of preformed Ex1Q49 seeds, which
stimulate the aggregation process (Fig. 7). Together,
these studies support our hypothesis that besides
primary nucleation and templated polymerization, also
nucleated branching plays a critical role in the Ex1Q49
aggregation process. At the date of publication, active
nucleated branching along existing fibrils has only been
described for glucagon [20] but, to our knowledge, has
not been theoretically modeled in the context of HD.
Our investigations of the early steps in the
aggregate formation cascade indicate that uncleaved
GST–Ex1Q49 fusion protein under non-denaturating
conditions is a stable oligomer, which has a very low
tendency to self-assemble into large aggregates.Upon
proteolytic cleavage with PP, however, GST–Ex1Q49
oligomers disintegrate and release aggregation-prone
Ex1Q49 molecules, which are most probably mono-
mers or small oligomers (see our DLS experiments,
1739Mutant Huntingtin Exon-1 FibrillogenesisFig. 1d). The released molecules then rapidly poly-
merize into largeSDS-stable aggregateswith a typical
fibrillar morphology (Fig. 1d and e). Our observations
therefore lead us to conclude that the large bundles of
fibrillar Ex1Q49 aggregates are spontaneously
formed in vitro from directly interacting monomers or
very small oligomers (dimers, trimers or tetramers),
which is in agreement with recently reported studies
[38]. However, they do not support observations that
the assembly of transient, relatively large spherical
oligomers is a critical early event in the spontaneous
HTTex1 aggregation cascade [34].
Our analysis of the early events in the Ex1Q49
aggregation cascade with DBAs and the epitope-
specific anti-polyQ antibodies MW1 and 3B5H10
indicates that both antibodies readily detect the
polyQ domain in uncleaved, soluble GST–Ex1Q49
oligomers (Fig. 2). However, MW1 antibody binding to
thepolyQdomainwas rapidly lost upon cleavageof the
GST fusion protein with PP. It has been shown
previously that the MW1 antibody recognizes short
linear epitopes in unfolded polyQ chains [52]. Our
results suggest that linear polyQchains are exposed to
MW1 in GST–Ex1Q49 oligomers but not in released
Ex1Q49 molecules. This supports previous reports
that pathogenic polyQ tracts collapse and assume
compact geometries in aqueous environments [62].
Previously published experiments also indicate that
long polyQ chains collapse when they are analyzed
with FRET or TR-FRET assays [63,64]. In contrast to
MW1, released soluble Ex1Q49 molecules are readily
detectable by the anti-polyQ antibody 3B5H10
(Fig. 2a), indicating that this antibody is less polyQ
conformation sensitive and recognizes both linear and
collapsed polyQ chains under non-denaturating
conditions.
We suggest that the proteolytically released
3B5H10-reactive Ex1Q49 molecules are compact
structures that have a relatively low β-sheet content
[54]. This is also supported by ThT dye-binding
experiments (Fig. 1c), which preferentially detect
higher-molecular-weight, β-sheet-rich Ex1Q49 aggre-
gates, but not soluble Ex1Q49 monomers and small
oligomers. Because of the low β-sheet content, we
hypothesize that the soluble molecules have to
undergo a conformational change into a stable
β-sheet structure in order to form fibrillar aggregates.
Such a conformational conversion is an energetically
unfavorable event; it may therefore occur only very
rarely in a large population of proteolytically released
molecules. However, once a stable β-sheet-rich mole-
cule has spontaneously formed, it may function as a
nucleus (or seed) that can efficiently convert other non-
β-sheet-rich Ex1Q49 molecules into an aggregation-
competent state. Thus, we propose a spontaneous
fibril formationmechanism inwhicha rare folding event
is the rate limiting step (Fig. 2a). This hypothesis is
supported by our theoretical modeling studies, indicat-
ing that a nucleus size of 1 (nc = 1) best describes thepolymerization of Ex1Q49 molecules into amyloid
fibrils (Fig. 5d). A conformational transition from a
non-β-sheet into a β-sheet structure has previously
been observed in soluble polyQ monomers with
biophysical methods [65], further substantiating the
theoretical results. However, our experimental data do
not exclude the possibility that instead of monomers
small Ex1Q49 oligomers (e.g., dimers, trimers or
tetramers) function as seeds and template fibril
assembly. They could form from interacting Ex1Q49
monomers by primary nucleation. Probably, they have
a compact β-hairpin conformation, which was previ-
ously predicted [66] and was recently identified with
high-resolution structural methods in fibrillar polyQ-
containing HTTex1 aggregates [67]. Interestingly, the
formation of HTTex1 tetramers has lately been
described in cell-free assays [33]. Whether they
function as nuclei (seeds) and can promote amyloid
fibrillogenesis, however, remains unknown. Additional
studies are therefore necessary to better elucidate the
very early steps in the HTTex1 aggregation cascade
and to describe the formation of small metastable
oligomers. Such structures have recently been directly
observed in the Ure2 aggregation process by using
single-molecule fluorescence microscopy [68].
Previous studies indicate that HTTex1 fibrils, once
they are formed, can further aggregate into even
more complex amyloid structures [34]. Our experi-
ments with preformed Ex1Q49 seeds (Fig. 7c–d) do
not support these results. Rather, we observed that
small Ex1Q49 fibrils, which are rapidly formed after
5–10 h (Fig. 7c), are very stable structures, which
cannot grow larger when all monomers are used up
and the aggregation reactions are incubated for
additional 40–45 h. Thus, the observed large bun-
dles of Ex1Q49 fibrils (Fig. 1e and f) are unlikely to
be formed by lateral association of small fibrils (see
Fig. S19) but rather are the result of nucleated
branching and templated polymerization (Fig. 5a). In
this case, an initially formed small seed or nucleus
grows into a large fibril bundle with multiple fibril ends
by monomer addition. Together, these studies
indicate that the mechanism underlying Ex1Q49
aggregation is distinct from that of other polypeptides
such as the 42-residue amyloid-β (Aβ42) peptide,
which forms unbranched fibrils [60]. Recent studies
have shown that Aβ42 fibrils can catalyze the
assembly of neurotoxic oligomers [19,69], indicating
that surface-catalyzed secondary nucleation events
play a key role in amyloidogenesis. In strong contrast
to Ex1Q49 branches, however, these oligomers are
not stably attached to the nucleating amyloid fibrils.
High-resolution studies indicate that, besides large
perinuclear inclusion bodies with highly complex
fibrillar structures [70,71], also smaller bundles of
fibrillar HTTex1 aggregates with pathogenic polyQ
tracts are detectable in the cytoplasm of mammalian
cells [72,73], supporting our hypothesis that sponta-
neous HTTex1 aggregation both in vitro and in vivo
1740 Mutant Huntingtin Exon-1 Fibrillogenesisis dominated by this fibril formation pathway. We
suggest that complex bundles of fibrillar HTT aggre-
gates are important disease-relevant structures. They
are very stable and unlikely to be degraded efficiently
by cellular protein quality systems such as autophagy.
This process was shown to be impaired in HD models
[74,75]. Complexbundles ofmutantHTTex1 fibrils also
might be responsible for the recruitment of multiple
critical factors, which could lead to aberrant cellular
functions. Recent studies indicate that many cellular
proteins aberrantly interact with mutant HTTex1
aggregates [76]. Also, experimental evidence was
obtained that proline-rich domains are exposed on the
surface of HTTex1 fibrils [77,78], suggesting that such
structures might efficiently recruit SH3 and WW
domain-containing signaling proteins and thereby
perturb their normal cellular functions. Such proteins
have previously been demonstrated to bind to mutant
HTTex1 aggregates in various disease models
[79,80]. Furthermore, recent studies indicate that
highly complex fibrillar HTTex1 structures interact
with endomembranes in cells and lead to their local
impairment [71]. Thus, the formation of complex
bundles of fibrillar HTT aggregates in neurons through
a nucleated branching mechanism may be of high
relevance for the development and progression of HD.
Ourmechanistic studies that suggest a critical role of
nucleated branching for Ex1Q49 aggregation have
several important implications for the development of
disease-modifying therapeutic strategies for HD. For
example, we found that the small moleculeO4 extends
the lag phase in the Ex1Q49 aggregation process
(Fig. 3a–f), indicating that it slows down the formation
of aggregation-competent conformations, which are a
prerequisite for fibril assembly. If we assume that
seeding-competent, fibrillar HTT aggregates are the
toxic species in pathogenesis [28], compounds like O4
should delay fibrillogenesis and improve symptoms
in HD patients. In order to be effective, however,
treatment with such compounds most probably would
need to start before fibrillar, seeding-competent
aggregates have formed, because propagation of
such structures in patient brains most likely cannot
be halted. Such specific questions can nowbe followed
up in experiments with transgenic and knock-in mouse
models of HD using our set of epitope-specific
antibodies and small molecules that target specific
events in the Ex1Q49 aggregation cascade.Materials and Methods
Protein purification and in vitro analysis of
aggregates
The proteins GST–Ex1Q49, GST–Ex1Q48–CyPet,
GST–Ex1Q48–YPet andGSTwereproduced inE. coli
BL21-RP cells and purified as described previously[25]. FRAs, DBAs, SDS-PAGE, DLS, size exclusion
chromatography and AFM of aggregates were per-
formed using standard methods. Details are provided
in Supplemental Methods,
HTTex1 protein aggregation
Aggregation of the Ex1Q49 fragment was initiated
by addition of 0.28 U PP to 2 μM GST–Ex1Q49
fusion protein [50 mM Tris (pH 7.4), 150 mM NaCl,
1 mM EDTA and 1 mM DTT]. Reactions were
incubated at 20 °C (300 rpm) for 1–8 h. Samples
were taken at indicated time points, frozen on dry ice
and stored at −80 °C. Aggregation of the Ex1Q48–
CyPet/–YPet fragments was performed under compa-
rable conditions. Details are provided in Supplemental
Methods.
Computational details for docking studies and
MD simulations
O4-Ex1Q47 docking studies were performed using
the program AutodockVina [55] and the previously
reported structuralmodel forEx1Q47 [53].QM/MMMD
simulations in explicit solvent were performed using
the program CHARMM (v33b13) [81] with the
CHARMM22 force field [82] for the MM region and
the SCC-DFTB-D [83] method for the QM region (O4
molecule). Classical MD simulations of Ex1Q47 and
Ex1Q46 [54] were performed with the NAMD program
[84]. The total combined simulated time in this study
reached 1.6 microseconds. More details are provided
in Supplemental Methods—Computational Details for
Docking Studies and MD Simulations.
Kinetic modeling
Models for the various aggregationmechanismsare
given by sets of ordinary differential equations
(ODEs). Binding and conformational transitions are
described bymass-action kinetics.Weusedmoments
of the distribution to derive a finite set of equations for
describing the aggregation process. These equations
are solved numerically using MATLAB ode15s
function. All details are provided in Supplemental
Methods—Kinetic Modeling of Ex1Q49 Aggregation.
In the model, the rate constant k1 accounts for the
binding to the template, that is, to all aggregates equal
or larger than the growth nucleus, and a conforma-
tional change of the monomers. To define a normal-
ization procedure and compare model simulations to
the FRA data, we used serial dilutions of reaction
mixtures and estimated the relationship between
relative protein amounts and relative immunoreactiv-
ities for the antibodies applied for aggregate detection
in FRAs (HD1 and CAG53b; Fig. S14a; Supplemental
Data, Eqs. S30 and S31). A log2 dependency was
used to convert simulated protein amounts to relative
immunoreactivities, which could then be compared
1741Mutant Huntingtin Exon-1 Fibrillogenesisto the measured values.Wemeasured GST–Ex1Q49
cleavage by PP over time and found that the cleavage
followed a Michaelis–Menten kinetics for which we
estimated the kinetic parameters (Fig. S14b; Supple-
mental Methods, Eq. S5). We also performed DBAs
with the CAG53b antibody at different time points after
addition of PP (Fig. S14c), which showed that
CAG53b detection efficiency was independent of the
Ex1Q49 aggregation state. This allowed to define the
relation between protein amounts and CAG53b signal
(Supplemental Methods, Eqs. S32–S33).
Supplementary data to this article can be found
online at https://doi.org/10.1016/j.jmb.2018.03.017.Acknowledgments
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